Incidence, rate ratio, and adjusted hazard ratio of secondary cancer evaluated between patients with and without multiple myeloma.

#<p>Rate, incidence rate, per 10,000 person-years.</p>*<p>IRR, multiple myeloma cohort to non-multiple myeloma cohort incidence rate ratio, per 10,000 person-years.</p>†<p>Adjusted HR, Cox model measured adjusted hazard ratio by adjustment for age and gender.</p>*<p>p<0.05,</p>**<p>p<0.01.</p><p>ICD-9-CM: hematologic malignancy, 201, 202, 204, 205, 206; Hodgkin's disease, 201; non-Hodgkin's lymphoma, 202; lymphoblastic leukemia, 204.0; myeloid leukemia, 205.0; monocytic leukemia, 206; solid tumor, 147, 150, 151, 153, 154, 155, 156, 157, 162, 173, 174, 185, 189, 193; nasopharyngeal cancer, 147; esophagus cancer, 150; gastric cancer, 151; colorectal cancer, 153; stomach cancer, 154; hepatoma, 155; gallbladder cancer, 156; pancreatic cancer, 157; lung cancer, 162; skin cancer, 173; breast cancer, 174; prostate cancer, 185; kidney cancer, 189; and thyroid cancer, 193.